Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-01

Clinical Trial Update: Efficacy, Safety, and Pharmacokinetics of Femoral Nerve Block With EXPAREL in Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial update on efficacy, safety, and pharmacokinetics of femoral nerve block with EXPAREL in total knee arthroplasty completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Exparel (liposomal bupivacaine)
  • Exparel (bupivacaine liposome injectable suspension) (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Pacira Pharmaceuticals, Inc | Conditions: Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-12-01